{
    "clinical_study": {
        "@rank": "45029", 
        "arm_group": {
            "arm_group_label": "Benzodiazepine-resistant", 
            "description": "those patients with either 1) a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs; 2) >40mg of diazepam (or diazepam equivalents) in 1 hr; or 3) an individual dose of 40 mg or greater of intravenous diazepam for control of agitation"
        }, 
        "brief_summary": {
            "textblock": "The overarching goal of this project is to improve the clinical quality of patients with\n      Benzodiazepine-resistant alcohol withdrawal syndrome."
        }, 
        "brief_title": "Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Benzodiazepine-resistant Alcohol Withdrawal Syndrome", 
        "condition_browse": {
            "mesh_term": "Substance Withdrawal Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        either\n\n          1. a requirement of either 200 mg of diazepam (or diazepam equivalents) in 4 hrs;\n\n          2. > 40mg of diazepam (or diazepam equivalents) in 1 hr; or\n\n          3. an individual dose of 40 mg or greater of intravenous diazepam for control of\n             agitation\n\n        Exclusion Criteria:\n\n          -  if < 18 years of age or had evidence of use of other illicit substances as determined\n             by urine toxicology screen"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "hospitalized inpatients"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01652326", 
            "org_study_id": "UPittsburgh 0031860"
        }, 
        "intervention": {
            "arm_group_label": "Benzodiazepine-resistant", 
            "intervention_name": "Diazepam", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Diazepam"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 25, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pittsburgh", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "15213"
                }, 
                "name": "UPMC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Identify those risk factors predictive of benzodiazepine-resistant alcohol withdrawal syndrome", 
            "safety_issue": "No", 
            "time_frame": "up to 38 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01652326"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Will compare the frequency, duration and dosages of the above agents when used for benzodiazepine-resistant alcohol withdrawal", 
                "measure": "Drug utilization of phenobarbital, propofol, dexmedetomidine, and ketamine in benzodiazepine-resistant alcohol withdrawal syndrome", 
                "safety_issue": "No", 
                "time_frame": "Up to 38 months"
            }, 
            {
                "description": "Comparative markers will include:\nPresence or absence of the following: delirium tremens, hallucinosis, seizures, or arrhythmias\nIndication and duration of mechanical intubation\nNosocomial infection rates\nICU length of stay", 
                "measure": "Effectiveness of phenobarbital, propofol, dexmedetomidine, and ketamine in benzodiazepine-resistant alcohol withdrawal", 
                "safety_issue": "No", 
                "time_frame": "Up to 38 months"
            }, 
            {
                "description": "Comparative markers will include:\nRikers Sedation Scale Assessments\nHypotension\nHypertriglyceridemia/Pancreatitis\nDrug induced hallucinosis or seizures", 
                "measure": "Tolerability of phenobarbital, propofol, dexmedetomidine, and ketamine in benzodiazepine-resistant alcohol withdrawal", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 38 months"
            }
        ], 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "collaborator": {
                "agency": "Hospira, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2012"
    }
}